PEAK6 Investments’s Alnylam Pharmaceuticals ALNY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | $163K | Sell |
591
-2,087
| -78% | -$574K | ﹤0.01% | 642 |
|
|
2024
Q2 | $651K | Sell |
2,678
-5,519
| -67% | -$1.34M | ﹤0.01% | 391 |
|
|
2024
Q1 | $1.23M | Buy |
8,197
+3,338
| +69% | +$499K | ﹤0.01% | 261 |
|
|
2023
Q4 | $930K | Sell |
4,859
-8,253
| -63% | -$1.58M | ﹤0.01% | 385 |
|
|
2023
Q3 | $2.32M | Buy |
13,112
+4,743
| +57% | +$840K | 0.01% | 176 |
|
|
2023
Q2 | $1.59M | Buy |
8,369
+1,591
| +23% | +$302K | 0.01% | 177 |
|
|
2023
Q1 | $1.36M | Buy |
6,778
+3,465
| +105% | +$694K | 0.01% | 273 |
|
|
2022
Q4 | $787K | Sell |
3,313
-2,431
| -42% | -$578K | ﹤0.01% | 406 |
|
|
2022
Q3 | $1.15M | Sell |
5,744
-2,625
| -31% | -$526K | ﹤0.01% | 455 |
|
|
2022
Q2 | $1.59M | Buy |
+8,369
| New | +$1.59M | ﹤0.01% | 553 |
|
|
2022
Q1 | – | Sell |
-4,704
| Closed | -$798K | – | 1672 |
|
|
2021
Q4 | $798K | Buy |
+4,704
| New | +$798K | ﹤0.01% | 654 |
|
|
2021
Q3 | – | Sell |
-14,820
| Closed | -$2.51M | – | 1779 |
|
|
2021
Q2 | $2.51M | Buy |
+14,820
| New | +$2.51M | 0.01% | 314 |
|
|
2021
Q1 | – | Sell |
-29,571
| Closed | -$3.84M | – | 1527 |
|
|
2020
Q4 | $3.84M | Buy |
29,571
+17,438
| +144% | +$2.27M | 0.01% | 294 |
|
|
2020
Q3 | $1.77M | Sell |
12,133
-20,396
| -63% | -$2.97M | ﹤0.01% | 393 |
|
|
2020
Q2 | $4.82M | Sell |
32,529
-5,181
| -14% | -$767K | 0.02% | 113 |
|
|
2020
Q1 | $4.11M | Buy |
37,710
+36,056
| +2,180% | +$3.92M | 0.02% | 110 |
|
|
2019
Q4 | $190K | Sell |
1,654
-24,577
| -94% | -$2.82M | ﹤0.01% | 734 |
|
|
2019
Q3 | $2.11M | Buy |
26,231
+20,861
| +388% | +$1.68M | 0.01% | 266 |
|
|
2019
Q2 | $390K | Buy |
+5,370
| New | +$390K | ﹤0.01% | 652 |
|
|
2019
Q1 | – | Hold |
0
| – | – | – | 1058 |
|